Publicaciones (167) Publicaciones de MARICELA VALERIO MINERO

2023

  1. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

  2. Clinical impact of time to results from the microbiology laboratory in bloodstream infections caused by carbapenemase-producing Enterobacterales (TIME-CPE STUDY)

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 8, pp. 1948-1954

  3. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  4. Cost analysis of disease including treatment with dalbavancin in a Spanish hospital: ECODAL ANALYSIS

    Journal of medical economics, Vol. 26, Núm. 1, pp. 463-472

  5. Demographic, clinical and microbiological characteristics of the first 30 human monkeypox confirmed cases attended in a tertiary hospital in Madrid (Spain), during the May-June 2022 international outbreak

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 36, Núm. 2, pp. 194-200

  6. Executive summary of the consensus statement of the group for the study of infection in transplantation and other immunocompromised host (GESITRA-IC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the treatment of SARS-CoV-2 infection in solid organ transplant recipients

    Transplantation Reviews

  7. Implementation and impact of an antibiotic control program and multidrug-resistant bacterial colonization in a liver transplant unit

    Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 7, pp. 357-361

  8. Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice

    Transplantation, Vol. 107, Núm. 3, pp. 762-773

  9. Long term SARS-CoV-2-specific cellular immunity after COVID-19 in liver transplant recipients

    Journal of Microbiology, Immunology and Infection, Vol. 56, Núm. 3, pp. 526-536

  10. Non-nosocomial Healthcare-Associated Infective Endocarditis: A Distinct Entity? Data from the GAMES Series (2008-2021)

    Open Forum Infectious Diseases, Vol. 10, Núm. 8

  11. Nosocomial Infections in Adult Patients Supported by Extracorporeal Membrane Oxygenation in a Cardiac Intensive Care Unit

    Microorganisms, Vol. 11, Núm. 4

  12. Pneumocystis jirovecii Pneumonia Diagnostic Approach: Real-Life Experience in a Tertiary Centre

    Journal of Fungi, Vol. 9, Núm. 4

  13. Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG

    Critical Care, Vol. 27, Núm. 1

  14. Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection

    Open Forum Infectious Diseases, Vol. 10, Núm. 2

  15. Systematic influenza screening in cardiac intensive care units during the influenza season: A prospective study in Spain

    International Journal of Infectious Diseases, Vol. 136, pp. 37-42

  16. Validation of the INCREMENT-SOT-CPE score in a large cohort of liver transplant recipients with carbapenem-resistant Enterobacterales infection

    Transplant Infectious Disease, Vol. 25, Núm. 2